Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC

Sunitinib has been used as the main therapy to treat the metastatic clear cell renal cell carcinoma (ccRCC) as it could function via suppressing the tumor growth and angiogenesis. Yet most ccRCC tumors may still regrow due to the development of sunitinib-resistance, and detailed mechanisms remain to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Death Dis
Main Authors: Gu, Junfei, Zhang, Yong, Han, Zhenwei, Gao, Lei, Cui, Jinfeng, Sun, Yin, Niu, Yuanjie, You, Bosen, Huang, Chi-Ping, Chang, Chawnshang, Wang, Xiaolu, Yeh, Shuyuan
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7224303/
https://ncbi.nlm.nih.gov/pubmed/32409702
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-020-2486-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados